Title: A Noninvasive Panel for Diagnosis of Esophageal Varices in Patients with Compensated Cirrhosis

Authors: El-Sayed Tharwa1, Khalid Gamil , Mohamed Abdel-Samiee, Osama El-Abd, Elhamy Abd-Almonem

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i3.77

Abstract

Background & Aim: Varices are present in 30-40 % of patients with compensated cirrhosis (Child–Pugh class A). Although screening endoscopy for esophageal varices (O.V.) is recommended to all patients with cirrhosis, this recommendation is not a result of evidence– based data. We studied the association of (platelet count / spleen diameter ratio, insulin resistance and splenoportal index) and the presence of O.V. in patients with compensated cirrhosis.

Patients and Methods: 124 patients with compensated liver cirrhosis due to chronic HCV were studied. After clinical, laboratory ultrasound examinations, all patients underwent screening endoscopy and O.V were reported as present or absent. According to presence or absence of varices; two groups were described. group I without varices and group II with varices.

Results: Among 124 patients with mean age of (51.81±12.94), 2 groups were described: group I (30 patients) and group II (94 patients) with a male majority (20 patients in group I and 66 patients in group II).In group I and group II: the mean platelet count/spleen diameter ratio was (1022.6±73.36, 608.76±58.44) respectively, the mean insulin resistance value was (2.426±0.618, 3.081± 0.474) respectively. The mean splenoportal index (SPI) value was (2.878± 0.870, 6.349± 0.514) respectively.

Conclusion: Low platelet count/spleen ratio and high SPI are very useful non invasive predictors for the presence of O.V. that could be used either separately or combined to decrease the number of upper GIT endoscopies needed in cirrhotic patients management, However insulin resistance as a non invasive predictor is still in need for further evaluation.

Keywords: Esophageal Varices, Cirrhosis, Spleno-portal index, Platelet count/spleen diameter, Insulin resistance.

References

1.   1.      Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External validation of the Platelet count/Spleen diameter ratio for the diagnosis of esophageal varices in Hepatitis C virus-related cirrhosis. Dig Dis Sci 2009; 54:654-60.

2.      Aiello A, Calapristi I, Freni MA, Fava A, Scarpignato EM, Spadaro A, et al. Assessment of portal hypertension in hepatic cirrhosis in relation to etiologic factors. Minerva Gastroenterol Dietol 1993; 39:1–5.

3.      Amarapurkar DN, Parikh SS, Shankaran K, Chopra K, Dhawan P, Kalro RH, et al. Correlation between splenomegaly and oesophageal varices in patients with liver cirrhosis. Endoscopy 1994; 26:563.  

4.      Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol 2008; 103:1159-67.

5.      Bolondi L, Zironi G, Gaiani S, Li Bassi S, Benzi G, Barbara L. Caliber of splenic and hepatic arteries and spleen size in cirrhosis of different etiology. Liver 1991; 11:198–205.

6.      Bressler B, Pinto R, El-Ashry D, Heathcote EJ. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? Gut 2005; 54:407-10. 

7.      Camma` C, Petta S, Vito Di Marco, Fabrizio Bronte, Stefania Ciminnisi, Giusalba Licata, Sergio Peralta, Fabio Simone, Giulio Marchesini, and Antonio Crax. Insulin Resistance Is a Risk Factor for Esophageal Varices in Hepatitis C Virus Cirrhosis. Hepatology 2009; 49:195-203.

8.      Chalasani N, Imperiale TF, Ismail A, Sood G, Carey M, Wilcox CM, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999; 94:3285-91.  

9.      Cherian JV, Deepak N, Ponnusamy RP, Somasundaram A, Jayanthi V. Non-invasive predictors of esophageal varices. Saudi J Gastroenterol 2011; 17:64-8.

10.  Dogru Teoman, Cemal Nuri Ercin, Serkan Tapan, Zülfikar Polat, Mustafa Gulsen, Sait Bagci. Insulin resistance in prediction of esophageal varices. Hepatology 2009; 49 (5): 1775–6.

11.  Emam E, Ayman Ramadan , Mohamad Badway, Hesham Atia, Mohamad Hamid Abo Warda, Heba Hassen Gawish. Prediction of oesophageal varices in patients with compensated cirrhosis: A novel scoring system. Arab Journal of Gastroenterology 10 (2009) 129–34.

12.  Erdozain Sosa JC, Martin Hervas C, Morena Blanco MA, Zapata  Aparicio I, Herrera Abian A, Conde Gacho P, et al. Color duplex  Doppler ultrasonography in the evaluation of the risk of esophageal  varices bleeding in cirrhotic patients. Gastroenterol Hepatol 2000; 23  (10):466-9 [Abstr].

13.  Esmat S. and Dalia Omran. Study of the Right Liver Lobe Size /Albumin Ratio as a Noninvasive Predictor of Oesophageal Varices Compared to: Spleen Size, Platelet Count and Platelet Count/Spleen Diameter Ratio in Post Hepatitis C Virus Liver Cirrhosis in Egypt. Journal of American Science 2011; 7(1):962-8.

14.  Garcia-Tsao G, D’Amico G, Abraldes JG, Schepis F, Merli M, Kim WR, et al. Predictive models in portal hypertension. In: de Franchis R, ed. Portal hypertension IV. Proceedings of the Fourth Baveno International Consensus Workshop on Methodology of Diagnosis and Treatment. Oxford, UK: Blackwell Science; 2006:47-100.

15.  Garcia-Tsao G, Escorsell A, Zakko M. Predicting the presence of significant portal hypertension and varices in compensated cirrhotic patients. Hepatology. 1997; 26:927-30. 

16.  Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: Proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003; 52:1200-5.

17.  Giannini E, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al . Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: Results of a multicenter, prospective, validation study. Am J Gastroenterol 2006; 101:2511-9.

18.  Gill ML, Atiq M, Sattar S, Khokhar N. Non-endoscopic parameters for the identification of esophageal varices in patients with chronic Hepatitis. J Pak Med Assoc 2004; 54: 575-7.

19.  Humera Khan,  Noor ul Iman. Thrombocytopenia predicts esophageal varices in chronic liver disease due to hepatitis B and C viruses. J. Med. Sci. (Peshawar, Print) January 2009, Vol. 17, No. 1:  30-4.

20.  Ismail F w , Hasnain A. Shah , Saeed Hamid, Zaigham Abbas ,Shahab Abid , Khalid Mumtaz , Wasim Jafri. Noninvasive predictors of large varices in patients hospitalized with gastroesophageal variceal hemorrhage Hepatol Int 2008: 2:124–8.

21.  Korner T. Portal duplex sonography in liver cirrhosis. A useful supplement to endoscopic evaluation of bleeding risk of esophageal varices? Scand J Gastroenterol 1996; 31(5):495-9.

22.  Liu C-H, Shih-Jer Hsu,Cheng-Chao Liang, Feng-Chiao Tsai, et al.  Esophageal Varices: Noninvasive Diagnosis with Duplex Doppler US in Patients with Compensated Cirrhosis Radiology: Volume 248: Number 1—July 2008; 132-9.

23.  Nashaat E H, Hossam Abd-Elaziz , Manal Sabry&Ahmed Aly Ibrahim. Non-Endoscopic Predictors of Esophageal Varices and Portal Hypertensive Gastropathy. Nature and Science 2010;8(6):43-50.

24.  Pilette C, Oberti F, Aube C, Rousselet MC, Bedossa P, Gallois Y. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999; 31:867-73.  

25.  Sarangapani A, Shanmugam C, Kalyanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol 2010; 16:38-42.

26.  Sarwar S, Khan AA, Butt AK, Shafqat F, Malik K, Ahmad I, et al. Non-endoscopic prediction of esophageal varices in cirrhosis. J Coll Physicians Surg Pak 2005;15:528-31.

27.  Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M,et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001; 33:333-8.

28.  Schwarzenberger E, Trinh Meyer, Vidushi Golla, Nicole Pena Sahdala, and Albert D. Min. Utilization of Platelet Count Spleen Diameter Ratio in Predicting the Presence of Esophageal Varices in Patients With Cirrhosis.  J Clin Gastroenterol 2010;44:146–50

29.  Sen S, Griffiths WJ. Non-invasive prediction of oesophageal varices in cirrhosis. World J Gastroenterol 2008; 14:2454-5. 

30.  Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J Gastroenterol Hepatol 2007; 22:1909-15.

31.  Stefanescu H, Mircea Grigorescu, Monica Lupsor, Anca Maniu, Dana Crisan, Bogdan Procopet, Diana Feier, Radu Badea. A New and simple Algorithm for the Noninvasive Assessment of Esophageal Varices in Cirrhotic Patients using serum Fibrosis Markers and transient Elastography. J Gastrointestin Liver Dis March 2011 Vol. 20 No 1, 57-64.

32.  Thabut D, Ratziu V, Trabut JB, Poynard T. Prediction of esophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut 2003; 52:1200-5.

33.  Thomopoulos KC, Labropoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003; 35:473-8.

34.  Wolf David C. Cirrhosis. Gastroenterol Clin North Am; 2004, 21:257-75.

35.  Yin XY, Lu MD, Huang JF, Xie Xy, Liang LJ. Color Doppler velocity profile assessment of portal hemodynamics in cirrhotic patients with portal hypertension: correlation with esophageal variceal bleeding. J Clin Ultrasound 2001; 29(1):7-13.

36.  Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 2001; 161:2564-70.  

Corresponding Author

El-Sayed Tharwa

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Telephone number:+2 01145202088, Fax number: +2 048 2234685